- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-Risk Non-Muscle-Invasive Bladder Cancer in United States
Total 339 results
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
Anchiano Therapeutics Israel Ltd.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Bladder Urothelial Carcinoma | Bladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Superficial Bladder Urothelial CarcinomaUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Netherlands, Portugal, Australia, Russian Federation, Ukraine
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
University of OxfordMerck Sharp & Dohme LLCTerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United Kingdom
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom, China, Japan, Brazil, Argentina
-
CepheidAxonal-Biostatem; Stève ConsultantsCompletedNon-muscle-invasive Bladder CancerUnited Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
The University of Texas Health Science Center at...TerminatedMuscle Invasive Bladder CancerUnited States
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruitingMuscle Invasive Bladder CancerUnited States, China
-
Janssen Research & Development, LLCActive, not recruitingUrinary Bladder NeoplasmsUnited States, Japan, China, Korea, Republic of, France, Belgium, Czechia, Taiwan, Italy, Poland, United Kingdom, Spain, Germany, Australia, Brazil, Argentina, India
-
Telormedix SACompletedCarcinoma in Situ | Non Muscle Invasive Bladder CancerUnited States
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Netherlands, Italy, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Greece, Israel, Japan, Russian Federation, Spain, Sweden
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedMuscle-Invasive Bladder Carcinoma | Bladder Cancer Stage II | Bladder Cancer Stage III | Bladder Cancer Stage IVUnited States
-
Masonic Cancer Center, University of MinnesotaBristol-Myers SquibbCompletedMuscle Invasive Bladder CancerUnited States
-
Prisma Health-UpstateRecruiting
-
UroGen Pharma Ltd.RecruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Urothelial Carcinoma Bladder | NMIBC | Urothelial Carcinoma Recurrent | Carcinoma in Situ of BladderUnited States, Italy, Spain
-
Lipac Oncology LLCTesoRx Pharma, LLCCompletedUrologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell TransitionalUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage 0is Bladder Urothelial Carcinoma | Stage I Bladder Urothelial Carcinoma | Stage 0 Bladder Urothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
Mamta ParikhNational Cancer Institute (NCI)RecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Recurrent Non-Muscle Invasive Bladder CarcinomaUnited States
-
University of MiamiTerminatedBladder Cancer | Bladder Carcinoma | Muscle Invasive Bladder Carcinoma | Transition Cell CancerUnited States
-
University of California, IrvineRecruitingMuscle-Invasive Bladder Cancer | Urothelial Bladder CancerUnited States
-
Omar MianGilead Sciences; Varian IncRecruitingMuscle-Invasive Bladder Carcinoma | Localized Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom
-
University of WashingtonBladder Cancer Advocacy NetworkRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Endo PharmaceuticalsTerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Non-muscle Invasive Bladder CancerUnited States
-
Dana-Farber Cancer InstitutePfizerRecruitingBladder Cancer | Muscle Invasive Bladder CancerUnited States
-
University of WashingtonGilead SciencesRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
University of WashingtonMerck Sharp & Dohme LLCRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; AmgenCompletedBladder Cancer | Muscle-invasive Bladder CancerUnited States
-
Sandy SrinivasGlaxoSmithKlineCompletedBladder Cancer | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUnited States
-
C2i GenomicsFox Chase Cancer Center; Baylor College of Medicine; New York University; The Cleveland... and other collaboratorsTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCG Oncology, Inc.; Richard M. Shulze Family FoundationActive, not recruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaUnited States
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerRecurrent Bladder Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage I Bladder Urothelial Carcinoma AJCC v6 and v7United States, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedCancer Survivors | Statin Use Among High Risk SurvivorsUnited States
-
UNC Lineberger Comprehensive Cancer CenterActive, not recruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaUnited States
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
Leslie BallasNot yet recruitingMuscle-Invasive Bladder Carcinoma | TumorUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States